Unveiling the Power of Semaglutide: Dr. Reddy's Paves the Way for Weight Loss Breakthroughs
Innovative Study to Tackle India’s Obesity Epidemic Dr. Reddy’s, a pharmaceutical giant, has secured regulatory approval to embark on a groundbreaking study of Semaglutide, a promising weight loss drug. This move marks a significant step towards addressing India’s growing obesity problem. Understanding Semaglutide Semaglutide is a GLP-1 agonist that mimics the effects of a hormone in the body responsible for regulating appetite and metabolism. Research has shown that Semaglutide can induce feelings of fullness, reduce cravings, and boost fat-burning abilities....